Overview

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of Haldol (haloperidol) and olanzapine in the control of chronic nausea with advanced cancer patients who have failed first line antiemetic therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Alberta Health Services
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Haloperidol
Haloperidol decanoate
Olanzapine